Please use this identifier to cite or link to this item: http://hdl.handle.net/1822/45142

TitleMetabolic reprogramming: a new relevant pathway in adult adrenocortical tumors
Author(s)Pinheiro, Celina
Granja, Sara Costa
Longatto Filho, Adhemar
Faria, André M.
Fragoso, Maria C. B. V.
Lovisolo, Silvana M.
Lerário, Antonio M.
Almeida, Madson Q.
Baltazar, Fátima
Zerbini, M. C. N.
KeywordsAdrenocortical tumors
Metabolic reprogramming
Monocarboxylate transporter
Warburg effect
Issue date2015
PublisherImpact Journals LLC
JournalOncotarget
Abstract(s)Adrenocortical carcinomas (ACCs) are complex neoplasias that may present unexpected clinical behavior, being imperative to identify new biological markers that can predict patient prognosis and provide new therapeutic options. The main aim of the present study was to evaluate the prognostic value of metabolism-related key proteins in adrenocortical carcinoma. The immunohistochemical expression of MCT1, MCT2, MCT4, CD147, CD44, GLUT1 and CAIX was evaluated in a series of 154 adult patients with adrenocortical neoplasia and associated with patients’ clinicopathological parameters. A significant increase in was found for membranous expression of MCT4, GLUT1 and CAIX in carcinomas, when compared to adenomas. Importantly MCT1, GLUT1 and CAIX expressions were significantly associated with poor prognostic variables, including high nuclear grade, high mitotic index, advanced tumor staging, presence of metastasis, as well as shorter overall and disease free survival. In opposition, MCT2 membranous expression was associated with favorable prognostic parameters. Importantly, cytoplasmic expression of CD147 was identified as an independent predictor of longer overall survival and cytoplasmic expression of CAIX as an independent predictor of longer disease-free survival. We provide evidence for a metabolic reprogramming in adrenocortical malignant tumors towards the hyperglycolytic and acid-resistant phenotype, which was associated with poor prognosis.
TypeArticle
URIhttp://hdl.handle.net/1822/45142
DOI10.18632/oncotarget.5623
ISSN1949-2553
Publisher versionhttp://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=5623&path%5B%5D=17566
Peer-Reviewedyes
AccessOpen access
Appears in Collections:ICVS - Artigos em Revistas Internacionais com Referee

Files in This Item:
File Description SizeFormat 
5623-96338-2-pb.pdf5,62 MBAdobe PDFView/Open

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID